Bristol-Myers Squibb Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 2, 2012 68 Pages - SKU: ICDR6792927 |
| Synopsis ICD Research's Bristol-Myers Squibb Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Bristol-Myers Squibb Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Bristol-Myers Squibb Company. ICD Research's Bristol-Myers Squibb Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Bristol-Myers Squibb Company (BMS) discovers, develops, licenses, manufactures and markets biopharmaceuticals and related healthcare products. It principally offers products in the fields of cancer, infectious diseases, psychiatry disorders, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis, cardiovascular and metabolic disorders and immune disorders. The company's products are sold to wholesalers, retail pharmacies, hospitals, government entities and medical professions. It focuses on research and development (R&D) activities to develop medicines for the treatment of serious diseases. The company operates in various regions across Asia, Europe, North America and Latin America. It has manufacture facilities in the US, Puerto Rico and in six other foreign countries. BMS is headquartered in New York, the US. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

